BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 222 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294,313 | +13.6% | 25,637 | +24.9% | 0.05% | +4.2% |
| Q3 2022 | $259,000 | -64.7% | 20,523 | -54.5% | 0.05% | -76.2% |
| Q1 2022 | $734,000 | +56.5% | 45,155 | +33.3% | 0.20% | +59.1% |
| Q4 2021 | $469,000 | +10.6% | 33,880 | +14.9% | 0.13% | +10.4% |
| Q3 2021 | $424,000 | -55.6% | 29,490 | -51.2% | 0.12% | -56.3% |
| Q2 2021 | $955,000 | +2413.2% | 60,429 | +449.9% | 0.26% | +1778.6% |
| Q4 2019 | $38,000 | – | 10,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |